The 20 Best Chronic Antibody-Mediated Rejection Doctors Near Me in Texas, US

Dr. Eric Siskind finds gratitude in being able to perform complex surgeries that improve the quality and quantity of life for his patients. He is board-certified in general surgery and has certification in kidney, pancreas, and liver transplantation from The American Society of Transplant Surgeons. Dr. Siskind areas of research focus on kidney, pancreas and liver transplantation and he has authored over 25 manuscripts and books chapters in various scientific publications. Dr. Siskind received the American Society of Transplant Surgeons Young Investigator Award in 2014 for his research. His areas of clinical focus include kidney transplantation, pancreas transplantation, liver transplantation, dialysis access surgery including vascular and peritoneal access, hepatobiliary surgery, minimally invasive nephrectomy surgery, as well as complex general surgery. Dr. Siskind earned his medical degree while attending the Albert Einstein College of Medicine at Yeshiva University in Bronx, N.Y. He completed his general surgery residency through Zucker School of Medicine at Hofstra University - Northwell Health System in Manhasset, N.Y. He went on to complete his transplant surgery fellowship training at the University of Maryland Medical Center in Baltimore. Dr. Siskind has been a transplant surgeon, assistant professor of surgery, and has performed over 300 transplant and complex surgeries in his career. He looks forward to bringing his knowledge, experience, and passion for patient care to further benefit patients within Texas Health. Dr. Siskind also serves on the Ethics Committee and Peer Support Committee for the American Society of Transplant Surgeons. When not with his patients, Dr. Siskind enjoys golfing, fishing, and cycling with his children. Dr. Siskind is also fluent in Spanish. Dr. Siskind is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Chronic Antibody-Mediated Rejection, Polycystic Kidney Disease, End-Stage Renal Disease (ESRD), Pancreas Transplant, and Kidney Transplant.

Abbas Rana, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Abbas Rana specializes in Surgery and works at BCM Surgery - Transplant. To make an appointment, please call (832) 355-1400. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Rana is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Hepatoblastoma, Chronic Antibody-Mediated Rejection, Liver Transplant, and Kidney Transplant. Dr. Rana is currently accepting new patients.

Dr Richard is a General Surgeon practicing medicine in Houston, Texas. Dr. Richard is rated as a Distinguished provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Polycystic Kidney Disease, Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Kidney Transplant, and Pancreas Transplant.

Jinping Fan is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Fan is rated as a Distinguished provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Chronic Antibody-Mediated Rejection, Gangrene, Chronic Inflammatory Demyelinating Polyneuropathy, Endoscopy, and Reconstructive Urology Surgery.

Jacqueline Lappin is a General Surgeon practicing medicine in Austin, Texas. Dr. Lappin is rated as a Distinguished provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Polycystic Kidney Disease, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant.

Michael Annabi is a primary care provider, practicing in Internal Medicine in El Paso, Texas. Dr. Annabi is rated as a Distinguished provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 100 other conditions, according to our data. His clinical expertise encompasses Sepsis, Peptic Ulcer, Urinary Tract Infection in Children, Endoscopy, and Gastrostomy.

Bruce Sheplan is a primary care provider, practicing in Internal Medicine in San Antonio, Texas. Dr. Sheplan is rated as a Distinguished provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Chronic Antibody-Mediated Rejection, Jaundice, Ureteral Reconstruction, and Gastrostomy.

Shankar Sanka is a primary care provider, practicing in Internal Medicine in San Antonio, Texas. Dr. Sanka is rated as a Distinguished provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Ascites, Gastrostomy, and Bone Marrow Aspiration.

Christine O'Mahony, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Christine O'Mahony specializes in Surgery and works at BCM Surgery - Transplant. To make an appointment, please call (832) 355-1400. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. O'mahony is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses End-Stage Renal Disease (ESRD), Chronic Antibody-Mediated Rejection, Liver Failure, Kidney Transplant, and Liver Transplant. Dr. O'mahony is currently accepting new patients.

Michelle Mcdonald is a Urologist practicing medicine in Dallas, Texas. Dr. Mcdonald is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Thin Basement Membrane Nephropathy, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant. Dr. Mcdonald is board certified in Urology- American Board Of Urology.

Richard Dickerman is a General Surgeon and a Transplant Surgeon practicing medicine in Dallas, Texas. Dr. Dickerman is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), Chronic Antibody-Mediated Rejection, Hernia, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant. Dr. Dickerman is board certified in General Surgery- American Board Of Surgery/General Surgery and General Surgery- American Board Of Surgery.

Kristene Gugliuzza is an Intensive Care Medicine provider practicing medicine in Galveston, Texas. Dr. Gugliuzza is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Stomach Cancer, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant.

Joseph Buell is a General Surgeon practicing medicine in Richardson, Texas. Dr. Buell is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Hepatitis, Liver Cancer, Fibrolamellar Carcinoma, Hepatectomy, and Kidney Transplant.

Dr. Martinez is a Clinical Assistant Professor at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. He is a fellowship-trained multi-organ abdominal transplant surgeon. He joined the transplant team at Baylor University Medical Center, part of Scott & White Health in 2018. Dr. Martinez performs liver, kidney and pancreas transplants and general surgical procedures on transplant patients. He received his medical degree at Florida State University. Dr. Martinez went on to complete a general surgery residency at University of Texas Health Science Center in Houston and then a fellowship in multi-organ abdominal transplantation at the University of Wisconsin in Madison. He is board-certified in general surgery with additional certification in abdominal transplantation. Dr. Martinez is an adjunct assistant professor with the Texas A&M Health Science Center and teaches residents and fellows at Baylor University Medical Center. His research interests include outcomes of dual organ transplants. He is committed to increasing awareness about living and deceased organ donation. In his free time, Dr. Martinez enjoys playing guitar, baseball, hiking, and spending time with his dogs. He is fluent in Spanish. Read more about Dr. Martinez's publications on PubMed.gov and the Baylor Health Sciences Library . Dr. Martinez is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Chronic Antibody-Mediated Rejection, Chylous Ascites, Pancreas Transplant, and Kidney Transplant. Dr. Martinez is board certified in Transplant Surgery- American Board Of Surgery/General Surgery, Transplant Surgery- American Board Of Surgery, and General Surgery- American Board Of Surgery.

Dr. Testa is a Clinical Professor at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. He is Chief of Abdominal Transplant at Baylor University Medical Center, part of Baylor Scott & White Health and Chairman of the Annette C. and Harold C. Simmons Transplant Institute. He specializes in living donor liver transplantation and is the principal investigator of the Uterine Transplant Clinical Trial that resulted in the first U.S. birth of a baby following uterine transplant. Dr. Testa was honored in 2018 as one of TIME Magazine's Top 100 for leading the medical team that performed the first successful uterus transplants in the nation. Dr. Testa is a graduate of t he University of Padova Medical School in Italy. After graduating cum laude, he completed a residency in general surgery at the same university. He went on to complete a general surgery residency at the University of Chicago and then a fellowship in abdominal organ transplant at Baylor University Medical Center in Dallas. Later at the University of Essen in Germany, he was instrumental in starting the first adult living donor liver transplant program in Europe. Dr. Testa returned to the U.S. in 2001, where he served as Director of Liver Transplant at the University of Illinois. In 2005, he moved to the University of Chicago where he rose to the rank of Professor of Surgery and served as Director of Liver Transplant and Hepatobilliary Surgery. Read more about Dr. Testa's publications on PubMed.gov and the Baylor Health Sciences Library. Dr. Testa returned to Baylor University Medical Center in 2011 to lead the Living Donor Liver Program. He became Chief of Abdominal Transplant for the Annette C. and Harold C. Simmons Transplant Institute in 2017. Dr. Testa is author or co-author of more than 160 publications and several book chapters. He is a recognized authority in Uterus Transplantation and Living Donor Liver Transplantation. His other interests include complex liver surgery of benign and malignant diseases. Read more about Dr. Testa Dr. Testa has been named one of Texas Monthly's Texas Super Doctors for over 10 years earning him a place on Texas Monthly's Hall of Fame list. Dr. Testa is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Hepatitis, Fibrolamellar Carcinoma, Liver Transplant, and Hysterectomy. Dr. Testa is board certified in Transplant Surgery- American Board Of Surgery/General Surgery and Transplant Surgery- American Board Of Surgery.

Johanna Bayer is a Clinical Associate Professor at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. Dr. Bayer is the surgical director of transplantation at Baylor Scott & White All Saints Medical Center – Fort Worth. She is the first female director of transplantation in the history of the Baylor Simmons Transplant Institute. As a multi-organ transplant surgeon, Dr. Bayer’s clinical focus is on living donor kidney transplant and living donor liver transplant. She is also part of the groundbreaking uterus transplant team at Baylor University Medical Center – Dallas. Dr. Bayer is accomplished in robotic nephrectomy – which allows live organ donors to recover quickly with minimal surgical discomfort or scarring. Dr. Bayer received her transplant surgery training at Baylor University Medical Center after completing her internship and residency at University of Texas Health Science Center in San Antonio. Dr. Bayer is originally from Germany where she began her medical education at Justus Liebig University in Giessen. Read more about Dr. Bayer's publications on PubMed.gov and the Baylor Health Sciences Library. Dr. Bayer is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Chronic Antibody-Mediated Rejection, Fibrolamellar Carcinoma, Liver Failure, Hysterectomy, and Kidney Transplant. Dr. Bayer is board certified in Transplant Surgery- American Board Of Surgery/General Surgery and Transplant Surgery- American Board Of Surgery.

Dr. Suzie Lee is a Clinical Assistant Professor at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. She is a multi-organ transplant surgeon, performing liver, kidney and pancreas transplants. Her professional interests include biliary disease and complex gastrointestinal issues of the pancreas and liver. As an accomplished hepatopancreatic biliary surgeon, she provides patients with innovative treatment and surgical options for liver, pancreas and bile duct cancer. After earning her medical degree from University of Pittsburgh School of Medicine, she completed her residency in general surgery at Vanderbilt University in Nashville, TN. She went on to complete a fellowship in abdominal transplant surgery at Washington University School of Medicine in St. Louis. Before pursuing medicine, Dr. Lee served in the Peace Corps in Mali, West Africa and worked as a book publicist in New York. Dr. Lee is active in the International Hepato-Pancreato Biliary Association and the American Society of Transplant Surgeons. When she is not operating, Dr. Lee enjoys exploring Texas and experiencing new adventures with her husband and children. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Fibrolamellar Carcinoma, Chronic Antibody-Mediated Rejection, Visceromegaly, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant. Dr. Lee is board certified in Transplant Surgery- American Board Of Surgery/General Surgery, Transplant Surgery- American Board Of Surgery, and General Surgery- American Board Of Surgery.

Dr. Wall is a Clinical Professor at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. She is board-certified in General Surgery by the American Board of Medicine with fellowship training in abdominal transplant surgery. She has clinical interests in liver, kidney and pancreas transplantation, as well as living liver and kidney donation. Her medical training began at Saint Louis University School of Medicine where she also received a PhD in Health Care Ethics. She completed her general surgery residency at Vanderbilt University Medical Center and her abdominal transplant surgery fellowship at Stanford University. Dr. Wall’s extensive research focuses on clinical ethical issues in surgical practice in general and transplantation, in particular, including how listing decisions are made and how organs are allocated. Dr. Wall has published a book entitled Ethics for International Medicine. Read more about Dr. Wall's publications on PubMed.gov and the Baylor Health Sciences Library . Dr. Wall is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Liver Failure, Chronic Antibody-Mediated Rejection, Hepatitis, Liver Transplant, and Kidney Transplant. Dr. Wall is board certified in Transplant Surgery- American Board Of Surgery/General Surgery and Transplant Surgery- American Board Of Surgery.

A native Houstonian, Dr. Ronald Cotton graduated valedictorian from the Michael E. DeBakey High School for Health Professions in 1998. Upon graduation, he entered the Houston Premedical Academy, an 8-year BS/MD program housed at the University of Houston and Baylor College of Medicine. Dr. Cotton completed a bachelor's of science in biology summa cum laude in 2002 and medical doctorate in 2006. After finishing medical school, he entered his general surgery residency at Baylor. During his residency, Dr. Cotton completed a two-year research fellowship at the Liver, Kidney and Pancreas Center and the Human Genome Sequencing Center at Baylor. There, his research interest centered on developing a high-quality tissue repository, and using these samples to detect genomic differences between Hepatitis B-, Hepatitis C-, and non-viral associated hepatocellular carcinoma. His research has resulted in numerous peer-reviewed publication as well as local, national and international presentations. Dr. Cotton has received numerous clinical accolades during his residency, including being named a 2012 Raleigh Ross Scholar by the Texas Surgical Society. Dr. Cotton is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Hepatoblastoma, Liver Failure, Hepatic Cystic Hamartoma, Liver Transplant, and Kidney Transplant. Dr. Cotton is currently accepting new patients.

Dr. Kayla Colvill is a board-certified general surgeon with fellowship training in abdominal transplant surgery. She holds additional certifications in endoscopic surgery and laparoscopic surgery. Dr. Colvill is skilled in a variety of surgical procedures including adult and pediatric kidney transplants, peritoneal dialysis access and general surgeries including hernia repairs in transplant candidates and recipients.Dr. Colvill earned her medical degree from McGovern Medical School at the University of Texas Health Science Center in Houston. She completed her general surgery residency at The University of Texas Medical Branch at Galveston and her abdominal transplant fellowship at UT Southwestern Medical Center in Dallas. Dr. Colvill is a member of the American College of Surgeons, American Medical Association, American Society of Transplant Surgeons, Association of Women Surgeons and Texas Medical Association. Away from the office, she enjoys traveling, doing yoga and Peloton workouts, and spending time with family and friends. Dr. Colvill is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. Her clinical expertise encompasses Polycystic Kidney Disease, End-Stage Renal Disease (ESRD), Hepatoblastoma, and Chronic Antibody-Mediated Rejection.